Eden Radioisotopes Secures State Backing for $1.4 Billion New Mexico Plant

New Mexico officials have committed a suite of financial incentives to the project, including job training grants and tax credits. The state anticipates the facility will generate over 200 permanent jobs and contribute $1.5 billion to the regional economy over the next decade. To manage the complex engineering and regulatory requirements, Eden has tapped Kiewit Nuclear Solutions to lead construction, while Sargent & Lundy continues its long-standing role in architectural and licensing support.

Currently, U.S. hospitals rely on aging international reactors for isotopes that often decay too rapidly for long-term stockpiling. Eden’s facility, rooted in research from Sandia National Laboratories, seeks to eliminate this dependency. The company filed its formal construction permit with the U.S. Nuclear Regulatory Commission in May, with a final decision expected by mid-2027. If approved, the site will represent a major shift in how the country sources materials essential for daily medical imaging and oncological care.